Monday, 20 December 2010

Beta-Cardone




Beta-Cardone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Beta-Cardone Tablets 80mg (SPC)

Ingredient matches for Beta-Cardone



Sotalol

Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Beta-Cardone in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nixoran




Nixoran may be available in the countries listed below.


Ingredient matches for Nixoran



Nitazoxanide

Nitazoxanide is reported as an ingredient of Nixoran in the following countries:


  • Argentina

International Drug Name Search

Sunday, 19 December 2010

Bidex 400


Generic Name: guaifenesin (Oral route)

gwye-FEN-e-sin

Commonly used brand name(s)

In the U.S.


  • Allfen

  • Altarussin

  • Amibid LA

  • Antitussin

  • Bidex 400

  • Diabetic Siltussin DAS-Na

  • Diabetic Tussin EX

  • Drituss G

  • Guaifenex G

  • Guaifenex LA

  • Mucinex

  • Robitussin

In Canada


  • Benylin-E

  • Benylin E Extra Strength Chest Congestion

  • Broncho-Grippex Expectorant

  • Robitussin Extra Strength

Available Dosage Forms:


  • Tablet, Extended Release

  • Solution

  • Capsule, Extended Release

  • Packet

  • Liquid

  • Tablet

  • Capsule

  • Elixir

  • Syrup

Therapeutic Class: Expectorant


Uses For Bidex 400


Guaifenesin is used to help clear mucus or phlegm (pronounced flem) from the chest when you have congestion from a cold or flu. It works by thinning the mucus or phlegm in the lungs.


This medicine is available both over-the-counter (OTC) and with your doctor's prescription.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Before Using Bidex 400


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Although there is no specific information comparing use of guaifenesin in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults. However, check with your doctor before using this medicine in children who have a chronic cough, such as occurs with asthma, or who have an unusually large amount of mucus or phlegm with the cough. Children with these conditions may need a different kind of medicine. Also, guaifenesin should not be given to children and infants younger than 2 years of age unless you are directed to do so by your doctor.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of guaifenesin in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Proper Use of guaifenesin

This section provides information on the proper use of a number of products that contain guaifenesin. It may not be specific to Bidex 400. Please read with care.


Drinking plenty of water while taking guaifenesin may help loosen mucus or phlegm in the lungs.


For patients taking the extended-release capsule form of this medicine:


  • Swallow the capsule whole, or open the capsule and sprinkle the contents on soft food such as applesauce, jelly, or pudding and swallow without crushing or chewing.

For patients taking the extended-release tablet form of this medicine:


  • If the tablet has a groove in it, you may carefully break it into two pieces along the groove. Then swallow the pieces whole, without crushing or chewing them.

  • If the tablet does not have a groove, it must be swallowed whole. Do not break, crush, or chew it before swallowing.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For regular (short-acting) oral dosage forms (capsules, oral solution, syrup, or tablets):
    • For cough:
      • Adults—200 to 400 milligrams (mg) every four hours.

      • Children 6 to 12 years of age—100 to 200 mg every four hours.

      • Children 4 to 6 years of age—50 to 100 mg every four hours.

      • Children and infants up to 4 years of age—Use is not recommended .



  • For long-acting oral dosage forms (extended-release capsules or tablets):
    • For cough:
      • Adults—600 to 1200 mg every twelve hours.

      • Children 6 to 12 years of age—600 mg every twelve hours.

      • Children 4 to 6 years of age—300 mg every twelve hours.

      • Children and infants up to 4 years of age—Use is not recommended .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Bidex 400


If your cough has not improved after 7 days or if you have a fever, skin rash, continuing headache, or sore throat with the cough, check with your doctor. These signs may mean that you have other medical problems.


Bidex 400 Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common or rare
  • Diarrhea

  • dizziness

  • headache

  • hives

  • nausea or vomiting

  • skin rash

  • stomach pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bidex 400 side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Bidex 400 resources


  • Bidex 400 Side Effects (in more detail)
  • Bidex 400 Use in Pregnancy & Breastfeeding
  • Bidex 400 Support Group
  • 0 Reviews for Bidex 400 - Add your own review/rating


Compare Bidex 400 with other medications


  • Bronchitis
  • Cough

Tuesday, 14 December 2010

Apo-Ibuprofen




Apo-Ibuprofen may be available in the countries listed below.


Ingredient matches for Apo-Ibuprofen



Ibuprofen

Ibuprofen is reported as an ingredient of Apo-Ibuprofen in the following countries:


  • Canada

  • Czech Republic

  • New Zealand

  • Singapore

  • Vietnam

International Drug Name Search

Friday, 10 December 2010

Thyrotardin




Thyrotardin may be available in the countries listed below.


Ingredient matches for Thyrotardin



Liothyronine

Liothyronine is reported as an ingredient of Thyrotardin in the following countries:


  • Germany

International Drug Name Search

Sunday, 5 December 2010

Kepakuru L




Kepakuru L may be available in the countries listed below.


Ingredient matches for Kepakuru L



Nifedipine

Nifedipine is reported as an ingredient of Kepakuru L in the following countries:


  • Japan

International Drug Name Search

Wednesday, 24 November 2010

Cefquinome




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0084957-30-2

Chemical Formula

C23-H24-N6-O5-S2

Molecular Weight

528

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

(Z)-7-[2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(5,6,7,8-tetrahydroquinoliniomethyl)-3-cephem-4-carboxylate

Foreign Names

  • Cefquinomum (Latin)
  • Cefquinom (German)
  • Cefquinome (French)
  • Cefquinoma (Spanish)

Generic Names

  • Cefquinome (OS: BAN)
  • HR 111V (IS: Hoechst)
  • Cefquinome Sulfate (OS: USAN)
  • Cefquinome Sulphate (OS: BANM)
  • HR 111 V-sulfate (IS: HoechstRoussel)

Brand Names

  • Cephaguard (veterinary use)
    Intervet, United Kingdom


  • Cobactan (veterinary use)
    Hoechst Roussel Vet, Portugal; Intervet, Netherlands; Intervet, Poland; Intervet, Poland; Intervet / Schering-Plough Animal Health, New Zealand


  • Cephaguard (veterinary use)
    Intervet, Ireland


  • Cobactan LA (veterinary use)
    Intervet, Netherlands


  • Cobactan (veterinary use)
    Intervet, Austria; Intervet, Belgium; Intervet, Germany; Intervet, France; Intervet, Italy; Intervet, Poland; Intervet, South Africa; Intervet / Schering-Plough Animal Health, New Zealand; Intervet International B.V., Luxembourg; Veterinaria, Switzerland; Virbac, France; Virbac, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 23 November 2010

Claritrox




Claritrox may be available in the countries listed below.


Ingredient matches for Claritrox



Clarithromycin

Clarithromycin is reported as an ingredient of Claritrox in the following countries:


  • Peru

International Drug Name Search

Monday, 22 November 2010

Nuvigil




In the US, Nuvigil (armodafinil systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Bipolar Disorder, Chronic Fatigue Syndrome, Depression, Hypersomnia, Jet Lag, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome and Shift Work Sleep Disorder.

US matches:

  • Nuvigil

Ingredient matches for Nuvigil



Armodafinil

Armodafinil is reported as an ingredient of Nuvigil in the following countries:


  • United States

International Drug Name Search

Friday, 19 November 2010

Benzapen-LA




Benzapen-LA may be available in the countries listed below.


Ingredient matches for Benzapen-LA



Benzylpenicillin

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Benzapen-LA in the following countries:


  • Turkey

International Drug Name Search

Thursday, 18 November 2010

Gyno-Daktar




Gyno-Daktar may be available in the countries listed below.


Ingredient matches for Gyno-Daktar



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Gyno-Daktar in the following countries:


  • Germany

International Drug Name Search

Cefaclor-Teva




Cefaclor-Teva may be available in the countries listed below.


Ingredient matches for Cefaclor-Teva



Cefaclor

Cefaclor is reported as an ingredient of Cefaclor-Teva in the following countries:


  • Israel

International Drug Name Search

Wednesday, 17 November 2010

Bithiol




Bithiol may be available in the countries listed below.


Ingredient matches for Bithiol



Ichthammol

Ichthammol is reported as an ingredient of Bithiol in the following countries:


  • Belgium

International Drug Name Search

Friday, 12 November 2010

Poratile




Poratile may be available in the countries listed below.


Ingredient matches for Poratile



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Poratile in the following countries:


  • Japan

International Drug Name Search

Oftalmolosa Cusi Aureomicina




Oftalmolosa Cusi Aureomicina may be available in the countries listed below.


Ingredient matches for Oftalmolosa Cusi Aureomicina



Chlortetracycline

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Oftalmolosa Cusi Aureomicina in the following countries:


  • Spain

International Drug Name Search

Thursday, 11 November 2010

Mexilétine




Mexilétine may be available in the countries listed below.


Ingredient matches for Mexilétine



Mexiletine

Mexilétine (DCF) is known as Mexiletine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 10 November 2010

Botox Cosmetic


Pronunciation: OH-na-BOT-ue-li-num-TOX-in-A
Generic Name: OnabotulinumtoxinA
Brand Name: Botox Cosmetic

Botox Cosmetic may spread from the injection site to other areas of the body, causing symptoms of a serious condition called botulism. These symptoms may occur hours to weeks after you receive Botox Cosmetic. Symptoms may include loss of strength; muscle weakness; double or blurred vision; drooping eyelids; hoarseness; change or loss of voice; loss of bladder control; or trouble speaking, breathing, or swallowing. The risk may be greater in children being treated for spasticity (muscle spasms), but these symptoms may also occur in adults. Botox Cosmetic is not approved for use in children. Contact your doctor immediately if these symptoms occur.


Severe and sometimes fatal breathing or swallowing problems have been reported. The risk may be greater in patients who already have breathing or swallowing problems. Tell your doctor if you have or are at risk of developing breathing or swallowing problems.





Botox Cosmetic is used for:

Temporarily improving the appearance of moderate to severe lines between the eyebrows in patients 65 years old or younger. It may also be used for other conditions as determined by your doctor.


Botox Cosmetic is a neurotoxin. It works by blocking nerve impulses to the muscles or sweat glands, temporarily paralyzing the muscle or gland.


Do NOT use Botox Cosmetic if:


  • you are allergic to any ingredient in Botox Cosmetic or another botulinum product

  • you have an infection at the injection site

  • you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.



Before using Botox Cosmetic:


Some medical conditions may interact with Botox Cosmetic. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have nerve problems or disease (eg, amyotrophic lateral sclerosis, motor neuropathy), muscle problems or disease (eg, Lambert-Eaton syndrome, myasthenia gravis), bleeding disorders, seizures, or severe weakness or wasting of the muscles at the injection site (eg, trouble raising your eyebrows, drooping eyelids)

  • if you have a history of heart problems (eg, irregular heartbeat, a recent heart attack), swallowing or breathing problems (eg, asthma), or eye problems (eg, glaucoma, drooping eyelid)

  • if you have a skin infection; or inflammation, scarring, or other skin disorders at the injection site

  • if you plan to have surgery, especially surgery on your face, or if you have received Botox Cosmetic or any other botulinum toxin within the past 4 months

  • if you have weakness in your forehead muscles, have had any change in the way your face normally looks, or you have had surgery on your face

  • if you are taking an allergy or cold medicine

Some MEDICINES MAY INTERACT with Botox Cosmetic. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Aminoglycoside antibiotics (eg, gentamicin), anticholinesterase medicines (eg, neostigmine), lincosamides (eg, clindamycin), magnesium, muscle relaxants (eg, cyclobenzaprine), neuromuscular blockers (eg, atracurium), polymyxin, quinidine, or sleep medicines (eg, zolpidem) because they may increase the risk of Botox Cosmetic's side effects

  • Anticoagulants (eg, warfarin) because the risk of bleeding at the injection site may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Botox Cosmetic may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Botox Cosmetic:


Use Botox Cosmetic as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Botox Cosmetic comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Botox Cosmetic refilled.

  • Botox Cosmetic is usually given as an injection at your doctor's office, hospital, or clinic.

  • If you miss a dose of Botox Cosmetic, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Botox Cosmetic.



Important safety information:


  • Botox Cosmetic may cause dizziness, drowsiness, loss of strength, weakness, blurred vision, or drooping eyelids. These effects may be worse if you take it with alcohol or certain medicines. Use Botox Cosmetic with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do NOT use more than the recommended dose or use Botox Cosmetic more often than every 3 months without checking with your doctor.

  • Tell your doctor or dentist that you take Botox Cosmetic before you receive any medical or dental care, emergency care, or surgery.

  • Do not switch brands of Botox Cosmetic. Contact your doctor if you have any questions.

  • Botox Cosmetic contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used Botox Cosmetic.

  • Botox Cosmetic should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Do not use Botox Cosmetic if you are pregnant. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Botox Cosmetic while you are pregnant. It is not known if Botox Cosmetic is found in breast milk. If you are or will be breast-feeding while you use Botox Cosmetic, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Botox Cosmetic:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Anxiety; back pain; dizziness; drowsiness; dry mouth; dry or irritated eyes; facial pain; flu-like symptoms; headache; inability to focus eyes; increased cough; indigestion; nausea; neck pain; pain, redness, swelling, or tenderness at the injection site; runny nose; sensitivity to light; stiff or weak muscles at or near the injection site; sweating.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bleeding at the injection site; chest pain; difficulty swallowing or breathing; double or blurred vision or other vision changes; drooping of the upper eyelid; eyelid swelling; fainting; fever, chills, or persistent sore throat; irregular heartbeat; loss of bladder control; loss of strength; paralysis; seizures; severe or persistent muscle weakness or dizziness; shortness of breath; speech changes or problems.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Botox Cosmetic side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include paralysis; severe muscle weakness; trouble swallowing; weak or shallow breathing.


Proper storage of Botox Cosmetic:

Botox Cosmetic is usually handled and stored by a health care provider. If you are using Botox Cosmetic at home, store Botox Cosmetic as directed by your pharmacist or health care provider. Keep Botox Cosmetic out of the reach of children and away from pets.


General information:


  • If you have any questions about Botox Cosmetic, please talk with your doctor, pharmacist, or other health care provider.

  • Botox Cosmetic is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Botox Cosmetic. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Botox Cosmetic resources


  • Botox Cosmetic Side Effects (in more detail)
  • Botox Cosmetic Use in Pregnancy & Breastfeeding
  • Botox Cosmetic Drug Interactions
  • Botox Cosmetic Support Group
  • 4 Reviews for Botox Cosmetic - Add your own review/rating


  • Botox Cosmetic Prescribing Information (FDA)

  • Botox Cosmetic Advanced Consumer (Micromedex) - Includes Dosage Information

  • Botox Prescribing Information (FDA)

  • Botox Monograph (AHFS DI)

  • Botox Consumer Overview

  • OnabotulinumtoxinA Professional Patient Advice (Wolters Kluwer)



Compare Botox Cosmetic with other medications


  • Facial Wrinkles

Monday, 8 November 2010

Iverhart Max




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Iverhart Max



Ivermectin

Ivermectin is reported as an ingredient of Iverhart Max in the following countries:


  • United States

Praziquantel

Praziquantel is reported as an ingredient of Iverhart Max in the following countries:


  • United States

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Iverhart Max in the following countries:


  • United States

International Drug Name Search

Sunday, 24 October 2010

Defobin




Defobin may be available in the countries listed below.


Ingredient matches for Defobin



Chlordiazepoxide

Chlordiazepoxide is reported as an ingredient of Defobin in the following countries:


  • Czech Republic

International Drug Name Search

Saturday, 23 October 2010

Roxifen




Roxifen may be available in the countries listed below.


Ingredient matches for Roxifen



Piroxicam

Piroxicam is reported as an ingredient of Roxifen in the following countries:


  • Singapore

International Drug Name Search

Friday, 15 October 2010

Sulfomyxin




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0001405-52-3

Therapeutic Category

Antibacterial: Polypeptide

Foreign Names

  • Sulfomyxinum (Latin)
  • Sulfomyxin (German)
  • Sulfomyxine (French)
  • Sulfomixina (Spanish)

Generic Name

  • Sulfomyxin (OS: USAN)

Brand Name

  • Dynamyxin (veterinary use)
    Pfizer Animal Health, United States

International Drug Name Search

Glossary

OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 13 October 2010

Atuxane




Atuxane may be available in the countries listed below.


Ingredient matches for Atuxane



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Atuxane in the following countries:


  • France

International Drug Name Search

Friday, 8 October 2010

Topiramat dura




Topiramat dura may be available in the countries listed below.


Ingredient matches for Topiramat dura



Topiramate

Topiramate is reported as an ingredient of Topiramat dura in the following countries:


  • Germany

International Drug Name Search

Wednesday, 6 October 2010

Lévulose Biosedra




Lévulose Biosedra may be available in the countries listed below.


Ingredient matches for Lévulose Biosedra



Fructose

Fructose is reported as an ingredient of Lévulose Biosedra in the following countries:


  • France

International Drug Name Search

Tuesday, 5 October 2010

Dex-Tuss


Generic Name: codeine and guaifenesin (KOE deen and gwye FEN a sin)

Brand Names: Allfen CD, Allfen CDX, Brontex, Cheracol with Codeine, Cheratussin AC, Dex-Tuss, Diabetic Tussin C, Duraganidin NR, ExeClear-C, Guaiatussin AC, Guaifen-C, Guiatuss AC, Guiatussin with Codeine, Iophen-C NR, M-Clear WC, Mar-cof CG, Mytussin AC, Robafen AC, Robitussin-AC, Tussi-Organidin NR, Tussi-Organidin-S NR, Tussiden C, Tusso-C


What is Dex-Tuss (codeine and guaifenesin)?

Codeine is in a group of drugs called narcotics. It is a cough suppressant that affects the signals in the brain that trigger cough reflex.


Guaifenesin is an expectorant. It helps loosen mucus congestion in your chest and throat, making it easier to cough out through your mouth.


The combination of codeine and guaifenesin is used to treat cough and to reduce chest congestion caused by upper respiratory infections or the common cold.


Codeine and guaifenesin will not treat a cough that is caused by smoking, asthma, or emphysema.

Codeine and guaifenesin may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dex-Tuss (codeine and guaifenesin)?


Ask a doctor or pharmacist before using any other cough or cold medicine. Guaifenesin is contained in many combination medicines. Taking certain products together can cause you to get too much guaifenesin. Check the label to see if a medicine contains an guaifenesin, or an expectorant. This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Codeine may be habit-forming and should be used only by the person it was prescribed for. This medication should never be shared with another person, especially someone who has a history of drug abuse or addiction. Keep the medication in a secure place where others cannot get to it. Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

What should I discuss with my healthcare provider before taking Dex-Tuss (codeine and guaifenesin)?


You should not take this medication if you are allergic to codeine or guaifenesin.

To make sure you can safely take codeine and guaifenesin, tell your doctor if you have any of these other conditions:



  • heart disease, heart rhythm disorder;




  • asthma, COPD, emphysema, or other breathing disorders;




  • a history of head injury or brain tumor;




  • epilepsy or other seizure disorder;




  • a stomach or intestinal disorder;




  • Addison's disease or other adrenal gland disorders;




  • curvature of the spine;




  • a thyroid disorder;



  • liver or kidney disease;


  • enlarged prostate; or




  • a history of depression, mental illness, or drug addiction;




FDA pregnancy category C. It is not known whether codeine and guaifenesin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Codeine may be habit forming and should be used only by the person it was prescribed for. Never share this medication with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it. Codeine can pass into breast milk and may harm a nursing baby. The use of codeine by some nursing mothers may lead to life-threatening side effects in the baby. Do not use this medication if you are breast-feeding a baby. Older adults may be more likely to have side effects from this medication.

Liquid forms of this medication may contain sugar or artificial sweetener (phenylalanine). Talk to your doctor before using this form of codeine and guaifenesin if you have diabetes or phenylketonuria (PKU).


How should I take Dex-Tuss (codeine and guaifenesin)?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take codeine and guaifenesin with food if it upsets your stomach. Drink extra fluids to help loosen the congestion and lubricate your throat while you are taking this medication.

Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Call your doctor if your symptoms do not improve after 7 days of treatment, or if you also have a fever, headache, or skin rash.

This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using codeine and guaifenesin.


Do not stop using this medication suddenly after long-term use or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using the medication. Store at room temperature away from moisture, heat, and light. Keep the bottle tightly closed when not in use.

Keep track of the amount of medicine used from each new bottle. Codeine is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.


What happens if I miss a dose?


Since cough medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of codeine can be fatal.

Overdose symptoms may include extreme dizziness or drowsiness, nausea, vomiting, sweating, confusion, hallucinations, cold and clammy skin, blue-colored lips or fingernails, weak or limp muscles, pinpoint pupils, weak pulse, slow breathing, fainting, or seizures (convulsions).


What should I avoid while taking Dex-Tuss (codeine and guaifenesin)?


This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Ask a doctor or pharmacist before using any other cough or cold medicine. Guaifenesin is contained in many combination medicines. Taking certain products together can cause you to get too much guaifenesin. Check the label to see if a medicine contains an guaifenesin, or an expectorant. Drinking alcohol can increase certain side effects of codeine and guaifenesin.

Dex-Tuss (codeine and guaifenesin) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop taking this medication and call your doctor at once if you have any of these serious side effects:

  • severe dizziness or drowsiness;




  • confusion, hallucinations, unusual thoughts or behavior;




  • urinating less than usual or not at all; or




  • slow heart rate, weak pulse, fainting, weak or shallow breathing.



Less serious side effects include:



  • dizziness, drowsiness, headache;




  • warmth, redness, or tingling under your skin;




  • nausea, vomiting, upset stomach;




  • constipation; or




  • skin rash or itching.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dex-Tuss (codeine and guaifenesin)?


Before taking this medication, tell your doctor if you regularly use other medicines that make you sleepy (such as allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by codeine and guaifenesin.

Also tell your doctor if you are using any of the following drugs:



  • cimetidine (Tagamet);




  • quinidine (Quin-G);




  • naloxone (Narcan); or




  • naltrexone (Vivitrol).



This list is not complete and other drugs may interact with codeine and guaifenesin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Dex-Tuss resources


  • Dex-Tuss Side Effects (in more detail)
  • Dex-Tuss Use in Pregnancy & Breastfeeding
  • Dex-Tuss Drug Interactions
  • Dex-Tuss Support Group
  • 0 Reviews for Dex-Tuss - Add your own review/rating


  • Brontex MedFacts Consumer Leaflet (Wolters Kluwer)

  • ExeClear-C Prescribing Information (FDA)

  • Guiatuss AC Liquid MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dex-Tuss with other medications


  • Cough


Where can I get more information?


  • Your pharmacist can provide more information about codeine and guaifenesin.

See also: Dex-Tuss side effects (in more detail)


Saturday, 2 October 2010

Convertase




Convertase may be available in the countries listed below.


Ingredient matches for Convertase



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Convertase in the following countries:


  • Algeria

International Drug Name Search

Tuesday, 21 September 2010

Alendronat Streuli




Alendronat Streuli may be available in the countries listed below.


Ingredient matches for Alendronat Streuli



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronat Streuli in the following countries:


  • Switzerland

International Drug Name Search

Friday, 17 September 2010

Betahistin-APC




Betahistin-APC may be available in the countries listed below.


Ingredient matches for Betahistin-APC



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betahistin-APC in the following countries:


  • Poland

International Drug Name Search

Thursday, 16 September 2010

P.P.




P.P. may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for P.P.



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of P.P. in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 14 September 2010

Renapar




Renapar may be available in the countries listed below.


Ingredient matches for Renapar



Amino Acids

Aspartic Acid dipotassium and magnesium (a derivative of Aspartic Acid) is reported as an ingredient of Renapar in the following countries:


  • Indonesia

International Drug Name Search

Friday, 10 September 2010

San-C




San-C may be available in the countries listed below.


Ingredient matches for San-C



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of San-C in the following countries:


  • Myanmar

International Drug Name Search

Sunday, 5 September 2010

Gastrimut




Gastrimut may be available in the countries listed below.


Ingredient matches for Gastrimut



Omeprazole

Omeprazole is reported as an ingredient of Gastrimut in the following countries:


  • Dominican Republic

  • El Salvador

  • Guatemala

  • Spain

International Drug Name Search

Wednesday, 18 August 2010

Ropitor




Ropitor may be available in the countries listed below.


Ingredient matches for Ropitor



Ropinirole

Ropinirole is reported as an ingredient of Ropitor in the following countries:


  • India

International Drug Name Search

Sunday, 15 August 2010

Sertralina Edigen




Sertralina Edigen may be available in the countries listed below.


Ingredient matches for Sertralina Edigen



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Edigen in the following countries:


  • Spain

International Drug Name Search

Saturday, 7 August 2010

Etoposido Biocrom




Etoposido Biocrom may be available in the countries listed below.


Ingredient matches for Etoposido Biocrom



Etoposide

Etoposide is reported as an ingredient of Etoposido Biocrom in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 4 August 2010

Nicam




Nicam may be available in the countries listed below.


UK matches:

  • Nicam 4% w/w Gel (SPC)

Ingredient matches for Nicam



Nicotinamide

Nicotinamide is reported as an ingredient of Nicam in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Co-Trimoxazol A




Co-Trimoxazol A may be available in the countries listed below.


Ingredient matches for Co-Trimoxazol A



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Co-Trimoxazol A in the following countries:


  • Netherlands

Trimethoprim

Trimethoprim is reported as an ingredient of Co-Trimoxazol A in the following countries:


  • Netherlands

International Drug Name Search

Monday, 26 July 2010

Vitagel




Vitagel may be available in the countries listed below.


Ingredient matches for Vitagel



Retinol

Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Vitagel in the following countries:


  • Germany

International Drug Name Search

Sunday, 25 July 2010

Oxaliplatin




In the US, Oxaliplatin (oxaliplatin systemic) is a member of the drug class alkylating agents and is used to treat Colorectal Cancer.

US matches:

  • Oxaliplatin

  • Oxaliplatin Intravenous

UK matches:

  • Oxaliplatin 5mg/ml powder for solution for infusion (Actavis UK Ltd)
  • Oxaliplatin 5mg/ml powder for solution for infusion (SPC)
  • Oxaliplatin Hospira 5 mg/ml Concentrate for Solution for Infusion (SPC)
  • Oxaliplatin Hospira 5 mg/ml Powder for Solution for Infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XA03

CAS registry number (Chemical Abstracts Service)

0061825-94-3

Chemical Formula

C8-H14-N2-O4-Pt

Molecular Weight

397

Therapeutic Category

Antineoplastic agent

Chemical Names

[(1R,2R)-1,2-Cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum (WHO)

Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(1R-trans))-

Foreign Names

  • Oxaliplatinum (Latin)
  • Oxaliplatin (German)
  • Oxaliplatine (French)
  • Oxaliplatino (Spanish)

Generic Names

  • Oxaliplatin (OS: BAN, USAN)
  • Oxaliplatine (OS: DCF)
  • 1670 RB (IS)
  • 1-OHP (IS)
  • Debiopharm (IS: NipponKayaku)
  • JM 83 (IS)
  • L-OHP (IS: NipponShinyaku)
  • NSC 266046 (IS)
  • RP 54780 (IS)
  • SR 96669 (IS)
  • Oxaliplatin (PH: BP 2010, Ph. Eur. 6)
  • Oxaliplatinum (PH: Ph. Eur. 6)

Brand Names

  • Axioplatin
    Apocare, Germany


  • Bendaplatin
    Bendalis, Germany


  • Crisapla
    LKM, Argentina


  • Croloxat
    Cell pharm, Germany


  • Dabenzol
    Filaxis, Argentina


  • Dacotin
    Dr. Reddys, India


  • Dacplat
    Pfizer, Argentina


  • Ebeoxal
    Ebewe Pharma, Slovakia


  • Elotaxin
    Sanofi-Aventis, Latvia


  • Eloxatin
    Aventis, Bulgaria; Chinoin, Bulgaria; Euro, Netherlands; Glaxo Wellcome, Bulgaria; Sanofi Aventis, Antigua & Barbuda; Sanofi Aventis, Netherlands Antilles; Sanofi Aventis, Barbados; Sanofi Aventis, Bermuda; Sanofi Aventis, Bahamas; Sanofi Aventis, Guyana; Sanofi Aventis, Haiti; Sanofi Aventis, Jamaica; Sanofi Aventis, Cayman Islands; Sanofi Aventis, Saint Lucia; Sanofi Aventis, Trinidad & Tobago; Sanofi Aventis, Saint Vincent & The Grenadines; Sanofi Winthrop, Bulgaria; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Estonia; Sanofi-Aventis, Egypt; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Israel; Sanofi-Aventis, Iraq; Sanofi-Aventis, Iran; Sanofi-Aventis, Italy; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Oman; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, Poland; Sanofi-Aventis, Qatar; Sanofi-Aventis, Romania; Sanofi-Aventis, Serbia; Sanofi-Aventis, Saudi Arabia; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Syria; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Aventis, Venezuela; Sanofi-Aventis, Vietnam; Sanofi-Aventis, Yemen; Sanofi-Aventis, South Africa; Sanofi-Aventis - Produtos farmacĂŞuticos, S.A., Portugal; Sanofi-Aventis S.A.U., Spain; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Jordan; Sanofi-Synthelabo, Luxembourg; Thissen, Bulgaria


  • Eloxatine
    Sanofi Aventis, Tunisia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Russian Federation


  • Elplat
    Yakult, Japan


  • Euroxaliplatin
    Lapharm, Germany


  • Glenoxal
    Glenmark, India


  • Kebir
    Aspen, Argentina


  • Medoxa
    Medac, Germany


  • Metaplatin
    Teva, Argentina


  • Mitog
    Microsules, Argentina


  • Oksaliplatin Ebewe
    Ebewe, Estonia; Ebewe, Lithuania


  • Oksaliplatin Medac
    medac, Estonia; medac, Lithuania


  • Oksaliplatin Merck
    Merck, Slovenia


  • Oksaliplatin Pliva
    Pliva, Slovenia


  • Oksaliplatin Teva
    Teva, Slovenia


  • Oloxayne
    Mayne, Estonia


  • Oplat
    Tecnofarma, Colombia


  • O-Plat
    Raffo, Argentina; Tecnofarma, Chile; Zodiac, Brazil


  • Otaplat
    UKR, Slovakia


  • Oxalatin
    Spirit Pharmaceuticals, Australia


  • Oxalip
    TTY Biopharm, Taiwan


  • Oxaliplan
    Cancernova, Germany


  • Oxaliplatin Arcana
    Arcana, Austria


  • Oxaliplatin Ebewe
    Ebewe, Austria; Ebewe, Hungary; Ebewe, Malta; Ebewe, Netherlands; Ebewe, Tunisia; Ebewe Pharma, Denmark; Meda, Sweden; WĂĽrth, Croatia (Hrvatska)


  • Oxaliplatin Gerolymatos
    png Gerolymatos, Greece


  • Oxaliplatin Hexal
    Hexal, Germany


  • Oxaliplatin Hosipra
    Hospira, Austria; Hospira, Belgium; Hospira, Germany; Hospira, Hungary; Hospira, Ireland; Hospira Nordic, Sweden


  • Oxaliplatin Hospira
    Hospira, Greece


  • Oxaliplatin Kabi
    Fresenius, Germany


  • Oxaliplatin Mayne
    Hospira, Luxembourg; Mayne, Denmark; Mayne, Estonia; Mayne, Ireland; Mayne, Lithuania; Mayne, Latvia


  • Oxaliplatin medac
    Medac, Austria; Medac, Finland; Medac, Greece; Medac, Hungary; Medac, Sweden


  • Oxaliplatin NC
    NeoCorp, Germany


  • Oxaliplatin onkovis
    Onkovis, Germany


  • Oxaliplatin Pliva
    Pliva, Bosnia & Herzegowina; Pliva, Czech Republic; Pliva, Croatia (Hrvatska); Pliva, Latvia


  • Oxaliplatin Sandoz
    Sandoz, Germany; Sandoz, Lithuania; Sandoz, Latvia


  • Oxaliplatin STADA
    Stada, Austria


  • Oxaliplatin Teva
    Pharmachemie, Latvia; Providens, Croatia (Hrvatska); Teva, Austria; Teva, Greece; Teva, Sweden


  • Oxaliplatin Vianex
    NordMedica, Sweden


  • Oxaliplatin Winthrop
    Sanofi-aventis, Czech Republic; Sanofi-aventis, Sweden; Sanofi-aventis, Slovenia; Winthrop, Germany; Winthrop, Denmark


  • Oxaliplatin
    Actavis, Malta; Ebewe, United States; Fresenius Kabi Oncology, United States; Hospira, Australia; Hospira, United States; Sun, United States; Teva, Norway; Teva USA, United States


  • Oxaliplatina Actavis
    Actavis, Slovakia


  • Oxaliplatina Winthrop
    Winthrop, Portugal


  • Oxaliplatin-Actavis
    Actavis, Austria; Actavis, Germany


  • Oxaliplatina-Teva
    Teva, Slovakia


  • Oxaliplatine Actavis
    Actavis, France


  • Oxaliplatine CF
    Centrafarm, Netherlands


  • Oxaliplatine Dakota Pharm
    Sanofi-Aventis, France


  • Oxaliplatine Ebewe
    Ebewe, France


  • Oxaliplatine EG
    Eurogenerics, Belgium


  • Oxaliplatine Fresenius
    Fresenius, Netherlands


  • Oxaliplatine Generics
    Generics, Greece


  • Oxaliplatine Hospira
    Hospira, France


  • Oxaliplatine Kabi
    Fresenius, France


  • Oxaliplatine Medac
    Medac, France; Medac, Netherlands; Teva, Belgium


  • Oxaliplatine Mylan
    Mylan, France; Mylan, Netherlands


  • Oxaliplatine ratiopharm
    Ratiopharm, France


  • Oxaliplatine Sanofi
    Sanofi-Aventis, Netherlands


  • Oxaliplatine Teva
    Teva, Belgium; Teva Santé, France


  • Oxaliplatin-GRY
    Teva-Gry, Germany


  • Oxaliplatino Biocrom
    Biocrom, Argentina


  • Oxaliplatino Delta
    Delta Farma, Argentina


  • Oxaliplatino Depronal
    Vegal, Spain


  • Oxaliplatino Ebewe
    Ebewe, Italy


  • Oxaliplatino Hospira
    Hospira, Italy


  • Oxaliplatino Mayne
    Hospira, Norway; Mayne, Spain


  • Oxaliplatino Medac
    Medac, Spain


  • Oxaliplatino Milo
    Teva, Spain


  • Oxaliplatino Ratiopharm
    Ratiopharm, Spain; Ratiopharm, Italy


  • Oxaliplatino Rontag
    Rontag, Argentina


  • Oxaliplatino Sandoz
    Sandoz, Colombia


  • Oxaliplatino Servycal
    Servycal, Argentina


  • Oxaliplatino Teva
    Teva, Spain; Teva, Italy


  • Oxaliplatino Varifarma
    Varifarma, Argentina


  • Oxaliplatino
    Baxter, Chile; Biocrom, Peru; Biolatina, Chile; Kampar, Chile; Servycal, Peru


  • Oxaliplatin-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Hungary


  • Oxaliprol
    Proel, Greece


  • Oxalisin
    Pharmachemie, Netherlands


  • Oxaliwin
    Winthrop, South Africa


  • Oxaltie
    BagĂł, Ecuador; Bioprofarma, Argentina


  • Oxaltina
    Meditrina, Greece


  • Oxerin
    Novamed, Colombia


  • Oxitel
    Dabur, Philippines


  • Oxitropic
    Ferrer, Spain


  • Platinostyl
    Ivax, Argentina; Ivax, Peru


  • Platox
    Hospira, Poland


  • Plusplatin
    Dosa, Argentina


  • Rexta
    Kalbe, Indonesia


  • Riboxatin
    Hikma, Germany


  • Riptam
    Asofarma, Mexico


  • Sinoxal
    Merck Sharp & Dohme, Poland


  • Tecnoplat
    Tecnofarma, Peru


  • Uxalun
    Novartis, Brazil; Sandoz, Argentina


  • Winthrop Oxaliplatin
    Sanofi-Aventis, Australia


  • Xaliplat
    Richmond, Argentina; Richmond, Peru

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 24 July 2010

DBL Metronidazole Intravenous Infusion




DBL Metronidazole Intravenous Infusion may be available in the countries listed below.


Ingredient matches for DBL Metronidazole Intravenous Infusion



Metronidazole

Metronidazole is reported as an ingredient of DBL Metronidazole Intravenous Infusion in the following countries:


  • Australia

International Drug Name Search

Thursday, 22 July 2010

Ardium




Ardium may be available in the countries listed below.


Ingredient matches for Ardium



Diosmin

Diosmin is reported as an ingredient of Ardium in the following countries:


  • Indonesia

Hesperidin

Hesperidin is reported as an ingredient of Ardium in the following countries:


  • Indonesia

International Drug Name Search

dutasteride and tamsulosin


doo-TAS-ter-ide, tam-SOO-loe-sin hye-droe-KLOR-ide


Commonly used brand name(s)

In the U.S.


  • Jalyn

Available Dosage Forms:


  • Capsule

Pharmacologic Class: 5-Alpha Reductase Inhibitor


Uses For dutasteride and tamsulosin


Note: Women of childbearing potential should not use or handle dutasteride and tamsulosin. Dutasteride can cause birth defects in male fetuses.


Dutasteride and tamsulosin combination is used to treat men who have symptoms of an enlarged prostate gland, which is also known as benign prostatic hyperplasia (BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. When the prostate gland gets larger, certain muscles in the gland get in the way of the tube that drains urine from the bladder. This can cause problems with urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely.


Dutasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate gland to grow. Dutasteride will cause the size of the prostate to decrease, but the effect lasts only as long as the medicine is taken. If it is stopped, the prostate begins to grow again.


Tamsulosin helps relax the muscles in the prostate gland and the opening of the bladder. This may help increase the flow of urine or decrease symptoms.


dutasteride and tamsulosin is available only with your doctor's prescription.


Before Using dutasteride and tamsulosin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dutasteride and tamsulosin, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to dutasteride and tamsulosin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Dutasteride and tamsulosin combination is not indicated for use in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dutasteride and tamsulosin combination in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dutasteride and tamsulosin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using dutasteride and tamsulosin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Atazanavir

  • Clarithromycin

  • Indinavir

  • Itraconazole

  • Ketoconazole

  • Nefazodone

  • Nelfinavir

  • Ritonavir

  • Saquinavir

  • Tadalafil

  • Telithromycin

Using dutasteride and tamsulosin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acebutolol

  • Alprenolol

  • Atenolol

  • Betaxolol

  • Bevantolol

  • Bisoprolol

  • Bucindolol

  • Carteolol

  • Carvedilol

  • Celiprolol

  • Cimetidine

  • Ciprofloxacin

  • Dilevalol

  • Diltiazem

  • Esmolol

  • Ketoconazole

  • Labetalol

  • Levobunolol

  • Mepindolol

  • Metipranolol

  • Metoprolol

  • Nadolol

  • Nebivolol

  • Oxprenolol

  • Paroxetine

  • Penbutolol

  • Pindolol

  • Propranolol

  • Ritonavir

  • Sildenafil

  • Sotalol

  • Talinolol

  • Tertatolol

  • Timolol

  • Vardenafil

  • Verapamil

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Other Medical Problems


The presence of other medical problems may affect the use of dutasteride and tamsulosin. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergy to sulfa drugs (such as sulfamethoxazole, sulfasalazine, sulfasoxazole, Azulfidine®, Bactrim®, or Septra®)—Increased allergic reaction in patients with this condition.

  • Hypotension (low blood pressure) or

  • Postural hypotension (low blood pressure when arising), history of or

  • Priapism (painful or prolonged erection of the penis)—Use with caution. May make these conditions worse.

  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of dutasteride and tamsulosin


Take dutasteride and tamsulosin exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


dutasteride and tamsulosin comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Take the capsule approximately 30 minutes after the same meal each day. Swallow the capsule whole. Do not chew or open it.


Dosing


The dose of dutasteride and tamsulosin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dutasteride and tamsulosin. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For benign prostatic hyperplasia:
      • Adults—One capsule once a day.

      • Children—Use is not recommended.



Missed Dose


If you miss a dose of dutasteride and tamsulosin, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using dutasteride and tamsulosin


It is very important that your doctor check your progress at regular visits to make sure that dutasteride and tamsulosin is working properly and to check for unwanted effects.


Women and children should not use dutasteride and tamsulosin. Pregnant women or women who may become pregnant should not handle or touch the capsules. Dutasteride can be absorbed through the skin and can cause birth defects in male fetuses. If a pregnant woman does come in contact with dutasteride and tamsulosin, the affected area should be washed right away with soap and water, especially if the capsule is broken.


Because dutasteride and tamsulosin may cause some people to become dizzy or feel faint, make sure you know how you react to dutasteride and tamsulosin before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.


Dizziness, lightheadedness, or fainting may occur after you take dutasteride and tamsulosin, especially when you get up suddenly from a lying or sitting position. Getting up slowly may help with this problem. If you feel dizzy, lie down so you do not faint. Then sit for a few moments before standing to prevent the dizziness from returning.


If you plan to have cataract surgery, tell your eye doctor (ophthalmologist) that you are taking dutasteride and tamsulosin or that you used dutasteride and tamsulosin in the previous 9 months. A serious eye problem called Intraoperative Floppy Iris Syndrome (IFIS) has occurred in some patients who were taking dutasteride and tamsulosin or who had recently taken dutasteride and tamsulosin when they had cataract surgery.


dutasteride and tamsulosin may affect the results of the prostate specific antigen (PSA) test, which may be used to detect prostate cancer. Make sure you tell all of your doctors that you are using dutasteride and tamsulosin.


dutasteride and tamsulosin will not prevent prostate cancer but may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns about this risk.


You should seek medical attention right away if you experience a prolonged erection while using dutasteride and tamsulosin. This is an extremely rare unwanted effect that must be treated right away to prevent permanent erectile damage (impotence).


Men who have taken dutasteride and tamsulosin should not donate blood until 6 months have passed since the last dose. Dutasteride can remain in your blood for a long time and be passed on to a pregnant woman who receives a blood transfusion.


dutasteride and tamsulosin does not usually affect normal sexual abilities for most men. You may notice that you ejaculate less fluid when you have sex.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


dutasteride and tamsulosin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Chills

  • cold sweats

  • confusion

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

Less common
  • Chest pain

  • cough or hoarseness

  • fever

  • lower back or side pain

  • painful or difficult urination

Incidence not known
  • Blistering, flaking, or peeling of the skin

  • blurred vision

  • difficulty with breathing

  • fast, irregular, pounding, or racing heartbeat or pulse

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • pain or swelling of the treated skin

  • painful or prolonged erection of the penis

  • shortness of breath

  • sweating

  • unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Change or problem with discharge of semen

  • decreased interest in sexual intercourse

  • dizziness

  • enlarged and painful breasts

  • inability to have or keep an erection

  • loss in sexual ability, desire, drive, or performance

Less common
  • Back pain

  • body aches or pain

  • congestion

  • diarrhea

  • dryness or soreness of the throat

  • headache

  • increased cough

  • lack or loss of strength

  • pain or tenderness around the eyes and cheekbones

  • runny nose

  • shortness of breath or troubled breathing

  • sleepiness or unusual drowsiness

  • sleeplessness

  • sneezing

  • stuffy nose

  • tender, swollen glands in the neck

  • tightness of the chest or wheezing

  • trouble sleeping

  • trouble with swallowing

  • unable to sleep

  • voice changes

Incidence not known
  • Constipation

  • hives or welts

  • itching

  • redness of the skin

  • skin rash

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: dutasteride and tamsulosin side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More dutasteride and tamsulosin resources


  • Dutasteride and tamsulosin Side Effects (in more detail)
  • Dutasteride and tamsulosin Dosage
  • Dutasteride and tamsulosin Use in Pregnancy & Breastfeeding
  • Dutasteride and tamsulosin Drug Interactions
  • Dutasteride and tamsulosin Support Group
  • 11 Reviews for Dutasteride and tamsulosin - Add your own review/rating


Compare dutasteride and tamsulosin with other medications


  • Benign Prostatic Hyperplasia

Friday, 16 July 2010

Neurodol




Neurodol may be available in the countries listed below.


Ingredient matches for Neurodol



Haloperidol

Haloperidol is reported as an ingredient of Neurodol in the following countries:


  • Tunisia

Lidocaine

Lidocaine is reported as an ingredient of Neurodol in the following countries:


  • Switzerland

International Drug Name Search

Monday, 12 July 2010

Nifecap




Nifecap may be available in the countries listed below.


Ingredient matches for Nifecap



Nifedipine

Nifedipine is reported as an ingredient of Nifecap in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 11 July 2010

Lormetazepam Germed




Lormetazepam Germed may be available in the countries listed below.


Ingredient matches for Lormetazepam Germed



Lormetazepam

Lormetazepam is reported as an ingredient of Lormetazepam Germed in the following countries:


  • Italy

International Drug Name Search